Details for Patent: 5,037,845
✉ Email this page to a colleague
Summary for Patent: 5,037,845
Title: | Indole derivative |
Abstract: | A compound of formula (I) ##STR1## and its physiologically acceptable salts and solvates are described as useful in treating and/or preventing pain resulting from dilatation of the cranial vasculature in particular migraine. The compound (I) may be prepared, for example, by cyclizing a compound of formula (II) ##STR2## |
Inventor(s): | Oxford; Alexander W. (Royston, GB2) |
Assignee: | Glaxo Group Limited (GB2) |
Application Number: | 07/317,682 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; Dosage form; |
Drugs Protected by US Patent 5,037,845
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,037,845
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 8419575 | Aug 01, 1984 |
International Family Members for US Patent 5,037,845
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 386196 | ⤷ Subscribe | |||
Austria | A226685 | ⤷ Subscribe | |||
Australia | 4568985 | ⤷ Subscribe | |||
Australia | 573878 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |